Am J Perinatol 2022; 39(03): 232-237
DOI: 10.1055/s-0041-1739355
SMFM Fellowship Series Article

Duration of Exposure to General Endotracheal Anesthesia during Cesarean Deliveries at Term and Perinatal Complications

1   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of California, San Francisco, San Francisco, California
2   Division of Medical Genetics, Department of Pediatrics, University of California, San Francisco, San Francisco, California
,
Luzhou Liang
3   Section of Obstetric Anesthesiology, Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
,
William A. Grobman
4   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
,
Nicole Higgins
3   Section of Obstetric Anesthesiology, Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
,
Archana Roy
5   Department of Obstetrics & Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
,
Moeun Son
6   Section of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University, New Haven, Connecticut
› Author Affiliations
Funding This study was funded by Northwestern University Clinical and Translational Sciences Institute grant UL1TR001422.

Abstract

Objective To examine whether the duration of time from initiation of general endotracheal anesthesia (GETA) to delivery for cesarean deliveries (CDs) performed is related to perinatal outcomes.

Study Design This is a retrospective study of patients with singleton nonanomalous gestations undergoing CD ≥37 weeks of gestation under GETA with reassuring fetal status at a single tertiary care center from 2000 to 2016. Duration from GETA initiation until delivery was calculated as the time interval from GETA induction to delivery (I-D), categorized into tertiles. Outcomes for those in the tertile with the shortest I-D were compared with those in the other two tertiles. The primary perinatal outcome was a composite of complications (continuous positive airway pressure or high-flow nasal cannula for ≥2 consecutive hours, inspired oxygen ≥30% for ≥4 consecutive hours, mechanical ventilation, stillbirth, or neonatal death ≤72 hours after birth). Secondary outcomes were 5-minute Apgar score <7 and a composite of maternal morbidity (bladder injury, bowel injury, and extension of hysterotomy). Bivariable and multivariable analyses were used to compare outcomes.

Results Two hundred eighteen maternal–perinatal dyads were analyzed. They were dichotomized based on I-D ≤4 minutes (those in the tertile with the shortest duration) or >4 minutes. Women with I-D >4 minutes were more likely to have prior abdominal surgery and less likely to have labored prior to CD. I-D >4 minutes was associated with significantly increased frequency of the primary perinatal outcome. This persisted after multivariable adjustment. In bivariable analysis, 5-minute Apgar <7 was more common in the group with I-D >4 minutes, but this did not persist in multivariable analysis. Frequency of maternal morbidity did not differ.

Conclusion When CD is performed at term using GETA without evidence of nonreassuring fetal status prior to delivery, I-D interval >4 minutes is associated with increased frequency of perinatal complications.

Key Points

  • Cesarean delivery under general anesthesia is associated with increased perinatal complications.

  • Perinatal complications are increased with increasing duration of exposure to general anesthetics.

  • Maternal complications were not increased with shorter duration of exposure to general anesthesia.

Note

This article was presented at the 66th Annual Meeting of the Society for Reproductive Investigation on March 14, 2019, in Paris, France.




Publication History

Received: 06 February 2021

Accepted: 04 October 2021

Article published online:
29 November 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Juang J, Gabriel RA, Dutton RP, Palanisamy A, Urman RD. Choice of anesthesia for cesarean delivery: an analysis of the national anesthesia clinical outcomes registry. Anesth Analg 2017; 124 (06) 1914-1917
  • 2 Hawkins JL, Chang J, Palmer SK, Gibbs CP, Callaghan WM. Anesthesia-related maternal mortality in the United States: 1979-2002. Obstet Gynecol 2011; 117 (01) 69-74
  • 3 Ozlu F, Yapıcıoglu H, Ulu B, Buyukkurt S, Unlugenc H. Do all deliveries with elective caesarean section need paediatrician attendance?. J Matern Fetal Neonatal Med 2012; 25 (12) 2766-2768
  • 4 Algert CS, Bowen JR, Giles WB, Knoblanche GE, Lain SJ, Roberts CL. Regional block versus general anaesthesia for caesarean section and neonatal outcomes: a population-based study. BMC Med 2009; 7: 20
  • 5 Nguyen-Lu N, Carvalho JC, Kingdom J, Windrim R, Allen L, Balki M. Mode of anesthesia and clinical outcomes of patients undergoing cesarean delivery for invasive placentation: a retrospective cohort study of 50 consecutive cases. Can J Anaesth 2016; 63 (11) 1233-1244
  • 6 Saygı Aİ, Özdamar Ö, Gün İ, Emirkadı H, Müngen E, Akpak YK. Comparison of maternal and fetal outcomes among patients undergoing cesarean section under general and spinal anesthesia: a randomized clinical trial. Sao Paulo Med J 2015; 133 (03) 227-234
  • 7 Lesage S. Cesarean delivery under general anesthesia: continuing professional development. Can J Anaesth 2014; 61 (05) 489-503
  • 8 Gyamfi-Bannerman C, Thom EA, Blackwell SC. et al; NICHD Maternal–Fetal Medicine Units Network. Antenatal betamethasone for women at risk for late preterm delivery. N Engl J Med 2016; 374 (14) 1311-1320
  • 9 Sánchez-Alcaraz A, Quintana MB, Laguarda M. Placental transfer and neonatal effects of propofol in caesarean section. J Clin Pharm Ther 1998; 23 (01) 19-23
  • 10 Gin T, Gregory MA, Chan K, Oh TE. Maternal and fetal levels of propofol at caesarean section. Anaesth Intensive Care 1990; 18 (02) 180-184
  • 11 Hu L, Pan J, Zhang S. et al. Propofol in combination with remifentanil for cesarean section: placental transfer and effect on mothers and newborns at different induction to delivery intervals. Taiwan J Obstet Gynecol 2017; 56 (04) 521-526
  • 12 Celleno D, Capogna G, Emanuelli M. et al. Which induction drug for cesarean section? A comparison of thiopental sodium, propofol, and midazolam. J Clin Anesth 1993; 5 (04) 284-288
  • 13 Siafaka I, Vadalouca A, Gatziou B, Petropoulos G, Salamalekis E. A comparative study of propofol and thiopental as induction agents for elective caesarean section. Clin Exp Obstet Gynecol 1992; 19 (02) 93-96
  • 14 Khemlani KH, Weibel S, Kranke P, Schreiber J. Hyponotic agents for induction of general anesthesia in cesarean section patients: a systematic review and meta-analysis of randomized controlled trials. J Clin Anesth 2018; (48) 73-80
  • 15 Montandrau O, Espitalier F, Bouyou J, Laffon M, Remérand F. Thiopental versus propofol on the outcome of the newborn after caesarean section: an impact study. Anaesth Crit Care Pain Med 2019; 38 (06) 631-635